Last update 14 Nov 2024
JMKX-001899
Last update 14 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms HBI-2438, HBI2438, JMKX 001899 + [3] |
Target |
Mechanism KRAS G12C inhibitors(GTPase KRas G12C inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationBreakthrough Therapy (CN) |
Login to view timeline
Related
10
Clinical Trials associated with JMKX-001899A Phase 1, Single Center, Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study to Evaluate the Effect of JMKX001899 on the QTc Interval in Healthy Subjects
a Single-center, Non-randomized, Open-label, Self-controlled Phase 1 Clinical Study to Evaluate Drug-drug Interactions of JMKX001899 Tablets in Healthy Subjects
评价JMKX001899片在健康受试者中药物-药物相互作用的单中心、 非随机、开放、自身对照的Ⅰ期临床试验
[Translation] A single-center, non-randomized, open-label, self-controlled phase I clinical trial to evaluate the drug-drug interactions of JMKX001899 tablets in healthy subjects
100 Clinical Results associated with JMKX-001899
Login to view more data
100 Translational Medicine associated with JMKX-001899
Login to view more data
100 Patents (Medical) associated with JMKX-001899
Login to view more data
100 Deals associated with JMKX-001899
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| KRAS G12C mutant Non-small Cell Lung Cancer | Phase 3 | CN | 04 Nov 2024 | |
| KRAS G12C mutation Solid Tumors | Phase 2 | CN | 12 May 2022 | |
| Solid tumor | Phase 1 | - | 01 Apr 2024 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | US | 01 Aug 2022 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | PR | 01 Aug 2022 | |
| Colonic Cancer | Phase 1 | US | 01 Aug 2022 | |
| Colonic Cancer | Phase 1 | PR | 01 Aug 2022 | |
| Non-Small Cell Lung Cancer | Phase 1 | US | 01 Aug 2022 | |
| Non-Small Cell Lung Cancer | Phase 1 | PR | 01 Aug 2022 | |
| Pancreatic Cancer | Phase 1 | US | 01 Aug 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free